In this podcast, Sean Delshad, MD, MBA, from Cedars-Sinai Center for Outcomes Research and Education, discusses the true extent of gastroesophageal reflux disease in the United States, the proportion of patients with GERD that is refractory to proton pump inhibitors, and prospects for new treatments of this common disease. More at: www.consultant360.com/gastroenterology